Kronos Bio Stock Quote KRON - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.05

Bid

1.04

Ask

1.09

Volume

538,697

1.04 Day's Range 1.16

0.69 52 Week Range 2.29

Market Cap

64.731M

Previous Close

1.06

Open

1.05

Last Trade

1.03

Last Trade Time

17:53:17

Financial Volume

$ 584,793

VWAP

1.0856

Average Volume (3m)

503,633

Shares Outstanding

58,316,520

Dividend Yield

PE Ratio

-0.57

Earnings Per Share (EPS)

-1.93

Revenue

6.29M

Net Profit

-112.67M

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kronosbio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRON. The last closing price for Kronos Bio was $1.06. Over the last year, Kronos Bio shares have traded in a share price range of $ 0.69 to $ 2.29.

Kronos Bio currently has 58,316,520 shares outstanding. The market capitalization of Kronos Bio is $64.73 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.57.

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

— KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed — — KB-0742 continues to show dose linear pharmacokinetics up to 80mg...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.3275	45.3287197232	0.7225	1.33	0.7151	1650502	1.08337196	CS
4	0.05	5	1	1.33	0.69	708903	0.97520152	CS
12	-0.15	-12.5	1.2	1.38	0.69	503633	1.00831514	CS
26	-0.4	-27.5862068966	1.45	1.5053	0.69	372036	1.06385623	CS
52	-0.64	-37.8698224852	1.69	2.29	0.69	322232	1.19781267	CS
156	-25	-95.9692898273	26.05	27.15	0.69	308988	5.46394735	CS
260	-27.24	-96.2884411453	28.29	39.605	0.69	294647	8.85227974	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHMDSCHMID Group NV	$ 5.60 (40.00%)	596
KAKineta Inc	$ 0.62 (21.69%)	4.84M
EMKREMCORE Corporation	$ 1.0099 (17.29%)	162.01k
MODDModular Medical Inc	$ 1.8658 (13.77%)	357
KITTNauticus Robotics Inc	$ 0.216 (12.50%)	3.07M
KAVLKaival Brands Innovations Group Inc	$ 4.5709 (-23.31%)	1.16M
OTRKOntrak Inc	$ 0.2053 (-17.35%)	5.33k
SPECSpectaire Holdings Inc	$ 0.37 (-13.93%)	23.07k
APVOAptevo Therapeutics Inc	$ 0.67 (-12.73%)	203.82k
VIRIVirios Therapeutics Inc	$ 0.21 (-11.84%)	196.24k
NDRAENDRA Life Sciences Inc	$ 0.11435 (10.38%)	33.13M
CRKNCrown Electrokinetics Corporation	$ 0.0618 (5.82%)	17.01M
KAKineta Inc	$ 0.62 (21.69%)	4.84M
NVDANVIDIA Corporation	$ 131.83 (-0.04%)	3.9M
GOEVCanoo Inc	$ 1.88 (4.44%)	3.74M